Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
George ArmahNoguchi Memorial Institute for Medical ResearchSamba O. SowCentre for Vaccine Development, Bamako, MaliRobert F. BreimanInternational Emerging Infections Program, Centers for Disease Control and Prevention, Atlanta, GA, USAMichael J. DallasMerck Research Laboratories, North Wales, PA, USAMilagritos D. TapiaCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USADaniel R. FeikinKenya Medical Research Institute and Centres for Disease Control and Prevention, Research and Public Health Collaboration, Kisumu, KenyaFred BinkaSchool of Public Health, University of Ghana, Accra, GhanaA. Duncan SteeleKayla F. LasersonCenter for Global HealthNana Akosua AnsahNavrongo Health Research Centre, Navrongo, GhanaMyron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USAKristen LewisPATH, Seattle, WA, USAMichele L. CoiaMerck Research Laboratories, North Wales, PA, USAMargaret Attah-PokuNoguchi Memorial Institute for Medical Research, University of Ghana, Accra, GhanaJoel OjwandoInternational Emerging Infections Program, Centers for Disease Control and Prevention, Atlanta, GA, USAStephen B. RiversMerck Research Laboratories, North Wales, PA, USAJohn C. VictorPATH, Seattle, WA, USAGeoffrey NyambaneKenya Medical Research Institute and Centres for Disease Control and Prevention, Research and Public Health Collaboration, Kisumu, KenyaAbraham HodgsonNavrongo Health Research Centre, Navrongo, GhanaF. SchödelMerck Research Laboratories, North Wales, PA, USAMax CiarletMerck Research Laboratories, North Wales, PA, USAKathleen M. NeuzilPATH, Seattle, WA, USA
2010en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba